Mechanistic studies and drug discovery for eEF-2 kinase
eEF-2K, also known as CaM kinase-III, is an atypical protein kinase which negatively regulates the global rate of protein synthesis through the phosphorylation and inactivation of its substrate eEF-2. Recently eEF-2K has been validated as a novel target for anti-cancer therapy. However, a detailed...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | en_US |
| Published: |
2013
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/2152/22246 |